Biocryst Pharmaceuticals buy Bank of America Co.
Start price
01.07.25
/
50%
€7.65
Target price
01.07.26
€12.73
Performance (%)
9.88%
End price
02.07.26
€8.41
Summary
This prediction ended on 02.07.26 with a price of €8.41. The BUY prediction by Bank_of_America_Co_ finished with a performance of 9.88%. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biocryst Pharmaceuticals | 3.869% | 3.869% | 15.701% |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % |
Comments by Bank_of_America_Co_ for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its price target raised by analysts at Bank of America Corporation from $13.00 to $15.00. They now have a "buy" rating on the stock.
Ratings data for BCRX provided by MarketBeat
In the thread Trading Biocryst Pharmaceuticals
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten